Stock IOVA IOVANCE BIOTHERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Iovance Biotherapeutics, Inc.

Equities

IOVA

US4622601007

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
11.64 USD +0.87% Intraday chart for Iovance Biotherapeutics, Inc. +2.92% +43.17%
Mar. 29 General (Ret.) Merrill A. McPeak, Member of the Board of Directors of Iovance Biotherapeutics, Inc. Retires and Not Stands for Re-Election CI
Mar. 14 Piper Sandler Adjusts Iovance Biotherapeutics Price Target to $19 From $18, Maintains Overweight Rating MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. IOVA Stock
  4. Revisions Iovance Biotherapeutics, Inc.